Time for a lead-time definition? Author response to ‘Why the length of recurrence free survival or “lead-times” can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis’

Detalles Bibliográficos
Autores principales: Spindler, Karen-Lise Garm, Callesen, Louise Bach, Arnold, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026177/
https://www.ncbi.nlm.nih.gov/pubmed/36950273
http://dx.doi.org/10.1177/17588359231156393
Descripción
Sumario:

Ejemplares similares